Highlights of January Journal of the American Dietetic Association

December 28, 2004

The January 2005 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this month's articles. For more information or to receive a faxed copy of a Journal article, e-mail media@eatright.org.

The Buzz on Caffeine
Coffee gets its perk from caffeine, and so do soft drinks and tea. According to researchers from the University of Vermont and the University of Maryland, these beverages are the top three dietary sources of caffeine among consumers. Using data from the National Continuing Survey of Food Intakes by Individuals, the authors categorized caffeine consumers by age and gender including children and pregnant women, and caffeine sources by food and beverage categories. The researchers found that nearly 90 percent of adults and male teens plus 76 percent of children consumed caffeine. Average caffeine consumption was 193 milligrams per day.

With coffee shops popping up on almost every street corner, it's not surprising that coffee remains the primary source of caffeine for adults. However, the per capita quantity of coffee consumed has decreased over the past 50 years, from 16 gallons per year to 9 gallons. Soft drinks have overtaken tea as the second source of caffeine intake for men aged 18 to 54 and women aged 18 to 34 years. For children aged 2 to 17, soft drinks were the primary source of caffeine. Caffeine consumed from energy beverages, caffeinated water, herbal supplements and medications were not included in this study.

Dietary Supplement Use among Chronically Ill Children
Researchers from the University of Utah surveyed a group of parents with chronically ill children to learn more about the use of prescribed and unprescribed dietary supplements. Nearly two-thirds (62 percent) of parents reported some form of dietary supplement use by their chronically ill children. While many children, especially those with certain illnesses such as cystic fibrosis, were routinely prescribed dietary supplements which can aid children by compensating for malabsorption, 30 percent reported using nonprescribed supplements.

A total of 198 different dietary supplement products were being used including vitamins, minerals, botanicals, amino acids, prebiotics/probiotics and combination products. In the majority of cases, the children's health-care providers were not aware the children were being given unprescribed supplements. Of parents who reported use of nonprescribed dietary supplements, only 20 percent had discussed their use with the child's physician. This creates the potential for adverse drug-herb interactions when the effects of many supplements on growth and development are unknown.
-end-
The Journal of the American Dietetic Association is the official research publication of the American Dietetic Association and is the premier peer-reviewed journal in the field of nutrition and dietetics.

With nearly 70,000 members, the American Dietetic Association is the nation's largest organization of food and nutrition professionals. Based in Chicago, ADA serves the public by promoting optimal nutrition, health and well-being. Visit ADA at www.eatright.org.

American Dietetic Association

Related Cystic Fibrosis Articles from Brightsurf:

Treating cystic fibrosis with mRNA therapy or CRISPR
The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation.

Cystic fibrosis: why so many respiratory complications?
Cystic fibrosis, one of the most common genetic diseases in Switzerland, causes severe respiratory and digestive disorders.

A newly discovered disease may lead to better treatment of cystic fibrosis
Cystic fibrosis is the most frequent severe inherited disorder worldwide.

New treatment kills off infection that can be deadly to cystic fibrosis patients
The findings, which are published in the journal Scientific Reports, show that scientists from Aston University, Mycobacterial Research Group, combined doses of three antibiotics -- amoxicillin and imipenem-relebactam and found it was 100% effective in killing off the infection which is usually extremely difficult to treat in patients with cystic fibrosis.

Cystic fibrosis carriers are at increased risk for cystic fibrosis-related conditions
A University of Iowa study challenges the conventional wisdom that having just one mutated copy of the cystic fibrosis (CF) gene has no effects on a person's health.

Rare mutations drive cystic fibrosis in Caribbean
Cystic Fibrosis (CF) in the Caribbean is dominated by unusual gene mutations not often observed in previously studied CF populations, according to comprehensive genome sequencing led by physician-scientists at UC San Francisco and Centro de Neumología Pediátrica in San Juan.

Cystic fibrosis carriers at increased risk of digestive symptoms
Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis.

In cystic fibrosis, lungs feed deadly bacteria
A steady supply of its favorite food helps a deadly bacterium thrive in the lungs of people with cystic fibrosis, according to a new study by Columbia researchers.

Cibio knocks out cystic fibrosis
The fight against cystic fibrosis continues, targeting in particular some of the mutations that cause it.

Hypertonic saline may help babies with cystic fibrosis breathe better
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Read More: Cystic Fibrosis News and Cystic Fibrosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.